Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Acquired Diseases
  • Published:

Modification of vascular tone using iNOS under the control of a radiation-inducible promoter

Abstract

It may be therapeutically advantageous to alter tumour blood supply specifically. Nitric oxide is a potent vasodilator which is produced in many tissues by the enzyme nitric oxide synthase (NOS). We have transfected cDNA for the inducible isoform of this enzyme (iNOS), under the control of the radiation-inducible promoter WAF1. The activity of the promoter was initially assessed using green fluorescent protein (GFP) in both endothelial cells and rat tail artery segments. Induction of protein expression by 9.5- and 4.5-fold respectively, was observed after a radiation dose of 4 Gy. Artery sections were then transfected with the WAF1/iNOS construct; this gave five-fold induction of iNOS protein after a dose of 4 Gy. The transfected artery was also tested functionally for relaxation, indicative of NO production. One hour after exposure to 4 Gy there was a significant (65%) relaxation of artery segments that had been preconstricted with phenylephrine. This could be partially reversed by the NOS inhibitor nitro-L-arginine. This study demonstrates that we can regulate vascular tone using an X-ray inducible promoter.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Kullo IJ, Simaro RD, Schartz RS . Vascular gene transfer from bench to bedside Arterioscler Thromb Vasc Biol 1999 19: 196–207

    Article  CAS  Google Scholar 

  2. Nabel EG et al. Recombinant fibroblast growth-factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo Nature 1993 362: 844–846

    Article  CAS  Google Scholar 

  3. Ohno T et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury Science 1994 265: 781–784

    Article  CAS  Google Scholar 

  4. Palu G et al. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans Gene Therapy 1999 6: 330–337

    Article  CAS  Google Scholar 

  5. Stewart AK et al. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial Gene Therapy 1999 6: 350–363

    Article  CAS  Google Scholar 

  6. Denekamp J . Vascular attack as a therapeutic strategy for cancer Cancer Metast Rev 1990 9: 267–282

    Article  CAS  Google Scholar 

  7. Geller DA, Billiar TR . Molecular biology of nitric oxide synthases Cancer Metast Rev 1998 17: 7–23

    Article  CAS  Google Scholar 

  8. Sherman PA et al. Purification and cDNA sequence of an iNOS from a tumour cell line Biochemistry 1993 32: 11600–11605

    Article  CAS  Google Scholar 

  9. Thomsen LL et al. NOS activity in human gynecological cancer Cancer Res 1994 54: 1352–1354

    CAS  PubMed  Google Scholar 

  10. Fujisawa H et al. Inducible nitric oxide synthase in a human glioblastoma cell line J Neurochem 1995 64: 85–91

    Article  CAS  Google Scholar 

  11. Kasahara N, Dozy A, Kan Y . Tissue-specific targeting of retroviral vectors through ligand–receptor interactions Science 1994 266: 1373–1376

    Article  CAS  Google Scholar 

  12. Manome Y et al. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene Cancer Res 1994 54: 5408–5413

    CAS  PubMed  Google Scholar 

  13. Gossen M, Bujard H . Tight control of gene expression in transgenic mice by tetracycline-responsive promoters Proc Natl Acad Sci USA 1992 89: 5547–5551

    Article  CAS  Google Scholar 

  14. Wang Y et al. A regulatory system for use in gene transfer Proc Natl Acad Sci USA 1994 91: 8180–8184

    Article  CAS  Google Scholar 

  15. Burcin MM et al. Adenovirus-mediated regulable target gene expression in vivo Proc Natl Acad Sci USA 1999 2: 355–360

    Article  Google Scholar 

  16. Weichselbaum RR et al. Gene therapy targeted by radiation preferentially radiosensitizes tumour cells Cancer Res 1994 54: 4266–4269

    CAS  Google Scholar 

  17. Hallahan DE et al. Spatial and temporal control of gene therapy using ionising radiation Nature Med 1995 8: 786–791

    Article  Google Scholar 

  18. Manome Y et al. Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the EGR-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine Hum Gene Ther 1998 9: 1409–1417

    Article  CAS  Google Scholar 

  19. Keyse SM . The induction of gene expression in mammalian cells by radiation Semin Cancer Biol 1993 4: 119–128

    CAS  PubMed  Google Scholar 

  20. El -Deiry SW et al. WAF1, a potential mediator of p53 tumour suppression Cell 1993 75: 817–825

    Article  CAS  Google Scholar 

  21. Ho YS, Wang YJ, Lin JK . Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells Mol Carcinog 1996 16: 20–31

    Article  CAS  Google Scholar 

  22. Miller N, Whelan J . Progress in transcriptionally targeted and regulable vectors for genetic therapy Hum Gene Ther 1997 8: 803–815

    Article  CAS  Google Scholar 

  23. Goud C et al. Cyclic GMP-independent mechanisms of nitric oxide induced vasodilation Gen Pharmacol 1999 1: 51–55

    Article  Google Scholar 

  24. Tzeng E et al. Expression of human inducible NO synthase in a tetrahydrobiopterin-deficient cell line: tetrahydrobiopterin promotes assembly of enzyme subunits into an active dimer Proc Natl Acad Sci USA 1995 92: 11771–11775

    Article  CAS  Google Scholar 

  25. Lancaster Jr JR . Simulation of the diffusion and reaction of endogenously produced nitric oxide Proc Natl Acad Sci USA 1994 91: 8137–8141

    Article  CAS  Google Scholar 

  26. Tzeng E et al. Vascular gene transfer of the human iNOS: characterisation of activity and effects on myointimal hyperplasia Mol Med 1996 2: 211–225

    Article  CAS  Google Scholar 

  27. McKeown SR et al. AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo Br J Cancer 1995 72: 76–81

    Article  CAS  Google Scholar 

  28. Morishita K, Johnson DE, Williams LT . A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression J Biol Chem 1995 270: 27948–27953

    Article  CAS  Google Scholar 

  29. Andes EW et al. HMEC-1 – establishment of an immortalised human microvascular endothelial cell line J Invest Dermatol 1992 99: 683–690

    Article  Google Scholar 

  30. Hirst DG et al. Upstream modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour Adv Exp Mod Biol 1994 345: 411–416

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Worthington, J., Robson, T., Murray, M. et al. Modification of vascular tone using iNOS under the control of a radiation-inducible promoter. Gene Ther 7, 1126–1131 (2000). https://doi.org/10.1038/sj.gt.3301224

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301224

Keywords

This article is cited by

Search

Quick links